Project Grant 2604938
Award Date 7/1/26
Completion Date 6/30/27
Dollars Obligated $305K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Clarksville, MD 21029, USA
Similar Awards
- Federal Grant Award Summary Gelastomerics LLC received a $305,000 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084), effective May 1, 2025 through April 30, 2028. The project focuses on research and development to establish the technical and commercial viability of a novel hydrogel elastomer technology designed to provide intrinsic lubricity for medical device applications. This...
- This $300,000 project grant from the National Science Foundation will fund research at Cornell University from October 1, 2022 to September 30, 2025. The award is provided through NSF's Engineering Biology and Health Cluster within the Directorate for Engineering, Biological Sciences and Biotechnology, under the CFDA program for Engineering. Specifically, researchers at Cornell University and Washington State University will work to develop new tissue engineering strategies for cartilage repair....
- Federal Grant Award Summary Cytrogen received a $305,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) to develop Gelatrix, an injectable light-curable bioadhesive designed for the treatment of bone defects. The award was obligated on July 15, 2026, with a completion date of June 30, 2027. The project aims to demonstrate the technical feasibility of a multifunctional...
- Federal Grant Award Summary Backstop Neural, Inc. received a $304,259 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) effective October 1, 2025, through June 30, 2026. The project will develop a minimally invasive spinal cord stimulation (SCS) lead utilizing shape memory polymer (SMP) technology to treat chronic pain. The novel 8-channel SMP-based paddle lead can be molded into a...
- Federal Grant Award Summary The National Science Foundation (NSF) awarded $305,000 through its Technology, Innovation, and Partnerships program (CFDA 47.084) to Limax Biosciences Inc. for a Phase I Small Business Innovation Research (SBIR) project commencing October 1, 2025 and concluding September 30, 2026. The award supports the development and optimization of HemoMax, a bioinspired hemostatic hydrogel adhesive designed to address uncontrolled bleeding in surgical settings. The hydrogel...
- Federal Project Grant Award Summary Flex Orthopaedics, Inc. received a $613,742 Project Grant award dated September 19, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The company will develop and optimize a compliant intramedullary stem design for revision total knee arthroplasty (RTKA) implants, with work to be completed by August 31, 2027. The device addresses...
- Cartilage Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation on February 15, 2021 to develop a biological adhesive for the fixation and integration of cartilage implants. The award is part of the Engineering program (CFDA 47.041) and will support Cartilage Inc.'s work through January 31, 2022. The Engineering program seeks to improve quality of life and economic strength through fostering innovation in engineering research and...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The goal is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them through the use of this biocompatible and antimicrobial nano-biological coating. The $305,000...
- This three-year, $1.2 million project grant from the National Science Foundation's Engineering program (CFDA 47.041) will support research at Washington State University and Cornell University to develop new tissue engineering strategies for cartilage regeneration. The researchers aim to stimulate adult stem cells to become mature chondrocytes for cartilage production through small molecules that interfere with bone cell differentiation genes. Real-time imaging will monitor cell growth...
- Federal Project Grant Award Summary Foogly Corp received a $305,000 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective October 1, 2025 through September 30, 2026. The project, performed at the company's Princeton, New Jersey location, focuses on developing low-cost soil amendment and coastal shoreline restoration products manufactured from upcycled food...